Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy.

Schenone, Aaron D

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy. [electronic resource] - Cancer medicine Jun 2014 - 603-12 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2045-7634

10.1002/cam4.209 doi


Aged
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Disease-Free Survival
Doxorubicin--administration & dosage
Epirubicin--administration & dosage
Female
Humans
Ifosfamide--administration & dosage
Male
Middle Aged
Risk Factors
Sarcoma--drug therapy